Found 0 matching trials
Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor
PHASE1This study is a four arm, parallel study.
Ten were administered a single s...
Location
Clinical Trials Center, Seoul National University Hospital
Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia
PHASE1Safety and efficacy studies of rHSA/GCSF fusion protein for injection in tr...
Location
Beijing Cancer Hospital
A Study of Flt3-Ligand Levels in Sjögrens Syndrome
N/AThe study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (C...
Location
Dept of Rheumatology, Sahlgrenska University Hospital
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
PHASE2The vast majority of patients with AML will die of the disease, and no stan...
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
PHASE1The objective of this phase I/ II study is therefore to assess the safety a...
Location
Centre Georges François Leclerc
Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
NAThe purpose of this study is to change the concentration of amyloid-beta in...
Location
Washington University Medical School
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
PHASE3The purpose of the study is to assess the safety and efficacy of targeted i...
Location
Multiple Locations
Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden
N/AAutoimmune encephalitis and paraneoplastic neurological syndromes are rare ...
Location
Uppsala University
The Effects of Primary Pterygium on Contrast Sensitivity Preoperatively and Postoperatively
N/APterygium is the growth of conjunctival tissue onto the cornea, usually fro...
Location
Zhongshan Opthalmic Center
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
PHASE2Patients included in the study will receive induction treatment during 6 mo...
Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona